GPC3 and hepatocellular carcinoma: Natarajan et al. [23] radiolabeled the humanized anti–GPC3 antibody H3K3 with 89Zr via a DFO chelator to create 89Zr-DFO–H3K3, which selectively binds GPC3-expressing HCC cells.